The Centre on Drug Policy Evaluation outlines how social responsibility and equity can be enhanced within Canadian cannabis legislation, emphasising the inclusion of underrepresented racialised people and genders, reparations for the harms of cannabis prohibition through reinvestment of taxes, and amnesty for previous cannabis convictions.
Harm Reduction International presents an update to key data in their flagship report - The Global State of Harm Reduction, including the launch of a new drug consumption room in Colombia.
The Civil Society Forum on Drugs seeks to address the neglected intersection of mental health and substance use in Europe and calls on policymakers, healthcare providers and society to strive for inclusive and compassionate mental health care for all.
Interrupting Criminalization, Drug Policy Alliance, and In Our Names Network advance a Black feminist approach to ending the war on drugs by centring the experiences of Black women, girls, and trans and gender-nonconforming people.
Fischer et al. assess five years of cannabis regulation, including in relation to reductions in contact with the criminal legal system and stable prevalence among young people, as well as concerning trends regarding emergency visits and intoxicated driving.
EHRA's regional assessment concludes that most health systems are not prepared to address the needs of people who use drugs, recommending changes in policy, professional guidance and community support to mitigate these shortcomings.
IDPC lays out the main challenges and opportunities offered by the upcoming 2024 mid-term review, underscoring that the objectives set out in 2019 have not been met and that a new approach is urgently needed.
AIDS Action Europe present guidance on adapting harm reduction principles to individuals engaged in chemsex, taking into account the intersectional identities of those involved.
The International Coalition on Drug Policy Reform and Environmental Justice shines a light on how global drug prohibition fuels organised crime, corruption and environmental devastation, and calls for closer collaboration between environmental and drug policy movements.
